ABCC7 p.Leu581Phe
Predicted by SNAP2: | A: N (87%), C: N (87%), D: N (57%), E: N (61%), F: N (97%), G: N (72%), H: N (78%), I: N (93%), K: N (66%), M: N (93%), N: N (72%), P: N (61%), Q: N (78%), R: N (66%), S: N (82%), T: N (93%), V: N (97%), W: N (78%), Y: N (97%), |
Predicted by PROVEAN: | A: N, C: N, D: N, E: N, F: N, G: N, H: N, I: N, K: N, M: N, N: N, P: N, Q: N, R: N, S: N, T: N, V: N, W: N, Y: N, |
[switch to compact view]
Comments [show]
None has been submitted yet.
[hide] Folding and rescue of a cystic fibrosis transmembr... J Biol Chem. 2010 Aug 27;285(35):27033-44. Epub 2010 Jun 15. Da Paula AC, Sousa M, Xu Z, Dawson ES, Boyd AC, Sheppard DN, Amaral MD
Folding and rescue of a cystic fibrosis transmembrane conductance regulator trafficking mutant identified using human-murine chimeric proteins.
J Biol Chem. 2010 Aug 27;285(35):27033-44. Epub 2010 Jun 15., 2010-08-27 [PMID:20551307]
Abstract [show]
Impairment of the cystic fibrosis transmembrane conductance regulator (CFTR) Cl(-) channel causes cystic fibrosis, a fatal genetic disease. Here, to gain insight into CFTR structure and function, we exploited interspecies differences between CFTR homologues using human (h)-murine (m) CFTR chimeras containing murine nucleotide-binding domains (NBDs) or regulatory domain on an hCFTR backbone. Among 15 hmCFTR chimeras analyzed, all but two were correctly processed, one containing part of mNBD1 and another containing part of mNBD2. Based on physicochemical distance analysis of divergent residues between human and murine CFTR in the two misprocessed hmCFTR chimeras, we generated point mutations for analysis of respective CFTR processing and functional properties. We identified one amino acid substitution (K584E-CFTR) that disrupts CFTR processing in NBD1. No single mutation was identified in NBD2 that disrupts protein processing. However, a number of NBD2 mutants altered channel function. Analysis of structural models of CFTR identified that although Lys(584) interacts with residue Leu(581) in human CFTR Glu(584) interacts with Phe(581) in mouse CFTR. Introduction of the murine residue (Phe(581)) in cis with K584E in human CFTR rescued the processing and trafficking defects of K584E-CFTR. Our data demonstrate that human-murine CFTR chimeras may be used to validate structural models of full-length CFTR. We also conclude that hmCFTR chimeras are a valuable tool to elucidate interactions between different domains of CFTR.
Comments [show]
None has been submitted yet.
No. Sentence Comment
157 Thus, we postulated that replacing Leu581 by a phenylalanine residue (as in mNBD1) might improve CFTR folding and rescue the processing defect of K584E-CFTR.
X
ABCC7 p.Leu581Phe 20551307:157:35
status: NEW158 To test this hypothesis, we introduced L581F in cis with K584E-CFTR by site-directed mutagenesis (L581F/K584E-CFTR) and generated the corresponding stable BHK cell line as well as one expressing L581F-CFTR.
X
ABCC7 p.Leu581Phe 20551307:158:39
status: NEWX
ABCC7 p.Leu581Phe 20551307:158:98
status: NEWX
ABCC7 p.Leu581Phe 20551307:158:195
status: NEW174 Error bars correspond to S.E. Folding of CFTR Chimeras AUGUST 27, 2010•VOLUME 285•NUMBER 35 JOURNAL OF BIOLOGICAL CHEMISTRY 27037 Fig. 4A demonstrates that both L581F- (lane 2) and L581F/ K584E- (lane 3) were detected as their fully glycosylated forms (band C) in contrast to K584E-CFTR (lane 1) for which only immature protein could be detected.
X
ABCC7 p.Leu581Phe 20551307:174:175
status: NEWX
ABCC7 p.Leu581Phe 20551307:174:176
status: NEW175 We interpret these data to suggest that K584E is rescued by L581F, possibly mediated by the side chain of phenylalanine 581 that most probably fills the empty space previously occupied by the side chain of Lys584 (Fig. 3B) as occurs in the structure of mNBD1 (Fig. 3C) (11).
X
ABCC7 p.Leu581Phe 20551307:175:60
status: NEW177 The magnitude of I-efflux elicited by L581F-CFTR (Fig. 4B and supplemental Fig. 3A) was smaller than that of WT-CFTR.
X
ABCC7 p.Leu581Phe 20551307:177:38
status: NEW178 However, that of L581F/K584E-CFTR was intermediate between L581F- and WT-CFTR (Fig. 4B and supplemental Fig. 3A).
X
ABCC7 p.Leu581Phe 20551307:178:17
status: NEWX
ABCC7 p.Leu581Phe 20551307:178:59
status: NEW182 To learn more about the stability of the K584E-, L581F-, and L581F/K584E-CFTR variants, we examined the turnover rate of FIGURE 3.
X
ABCC7 p.Leu581Phe 20551307:182:49
status: NEWX
ABCC7 p.Leu581Phe 20551307:182:61
status: NEW187 TABLE 1 Summary information of CFTR point mutants analyzed in present study CFTR variants Clinical dataa Band C/band Bb (؎S.E., n ؍ 5) Processingc Normalized processingd Normalized iodide efflux functione (؎S.E., n ؍ 6) Iodide efflux to processed proteinf % % % % peak intensity % WT-CFTR -g 83 Ϯ 3 77 100 100 Ϯ 8 - Murine - 86 Ϯ 5 66 86 74 Ϯ 4 86 Ϯ 4 E527Q Mild CF 64 Ϯ 5 49 63 46 Ϯ 4 73 Ϯ 4 E528Q - 86 Ϯ 5 79 102 135 Ϯ 16 132 Ϯ 10 S531T - 87 Ϯ 6 81 105 71 Ϯ 5 67 Ϯ 5 K536Q - 69 Ϯ 3 42 54 51 Ϯ 4 94 Ϯ 3 I539T Revertant 112 Ϯ 5 81 105 49 Ϯ 6 46 Ϯ 5 L581F - 118 Ϯ 3 83 107 72 Ϯ 5 67 Ϯ 3 L581F/K584E - 125 Ϯ 2 77 100 100 Ϯ 12 100 Ϯ 8 T1263I Mild CF 75 Ϯ 3 76 98 31 Ϯ 8 31 Ϯ 5 P1290T Asymptomatic 87 Ϯ 3 82 106 92 Ϯ 10 86 Ϯ 6 K1302Q - 72 Ϯ 3 77 100 37 Ϯ 2 37 Ϯ 2 Y1307N - 82 Ϯ 2 76 98 70 Ϯ 5 71 Ϯ 3 Q1309K - 79 Ϯ 4 77 100 26 Ϯ 2 26 Ϯ 3 S1311K - 73 Ϯ 4 72 93 33 Ϯ 7 35 Ϯ 5 R1325K - 64 Ϯ 6 78 101 47 Ϯ 2 46 Ϯ 4 V1338T - 88 Ϯ 2 77 100 37 Ϯ 11 37 Ϯ 6 C1344Y - 71 Ϯ 4 76 98 86 Ϯ 4 87 Ϯ 4 L1367I - 72 Ϯ 5 80 103 36 Ϯ 5 34 Ϯ 5 D1394G - 78 Ϯ 4 86 111 93 Ϯ 12 83 Ϯ 8 E1409D - 70 Ϯ 3 70 90 43 Ϯ 5 47 Ϯ 4 a Data from the CFTR mutation database.
X
ABCC7 p.Leu581Phe 20551307:187:725
status: NEWX
ABCC7 p.Leu581Phe 20551307:187:780
status: NEW194 Pulse-chase analyses followed by CFTR immunoprecipitation (Fig. 4C) demonstrate that the turnover rates of band B of both L581F- (Fig. 4D, open squares) and L581F/K584E-CFTR (Fig. 4D, filled triangles) were the same as those of WT-CFTR (Fig. 4D, filled circles).
X
ABCC7 p.Leu581Phe 20551307:194:122
status: NEWX
ABCC7 p.Leu581Phe 20551307:194:157
status: NEW195 However, the turnover rate of K584E-CFTR (Fig. 4D, filled diamonds) was significantly (p Ͻ 0.05) reduced compared with those of L581F-, L581F/K584E-, WT-, and F508del-CFTR (Fig. 4D, open squares, filled triangles, filled circles, and open circles, respectively).
X
ABCC7 p.Leu581Phe 20551307:195:134
status: NEWX
ABCC7 p.Leu581Phe 20551307:195:136
status: NEW196 Consistent with the data in Fig. 4D, the processing efficiencies of L581F- (Fig. 4E, open squares) and L581F/ K584E-CFTR (Fig. 4E, filled triangles) were not significantly different from those of WT-CFTR (Fig. 4D, filled circles).
X
ABCC7 p.Leu581Phe 20551307:196:68
status: NEWX
ABCC7 p.Leu581Phe 20551307:196:103
status: NEW197 Taken together, these data suggest that the immature form of K584E-CFTR is significantly stabilized compared with those of L581F-, L581F/K584E-, WT-, and even F508del-CFTR.
X
ABCC7 p.Leu581Phe 20551307:197:123
status: NEWX
ABCC7 p.Leu581Phe 20551307:197:131
status: NEW198 Localization of K584E-, L581F-, and L581F/K584E-CFTR by Immunofluorescence-Our biochemical studies demonstrated that K584E-CFTR is only detected in its immature form, suggesting that it is misfolded and retained in the ER.
X
ABCC7 p.Leu581Phe 20551307:198:24
status: NEWX
ABCC7 p.Leu581Phe 20551307:198:36
status: NEW199 To test this possibility and learn whether the biochemically detected rescue of K584E-CFTR by L581F-CFTR (mature form) indeed corresponds to protein present at the cell surface, we used immunofluorescence and confocal microscopy.
X
ABCC7 p.Leu581Phe 20551307:199:94
status: NEW201 By contrast, L581F- (D1), L581F/ K584E- (E1), and WT-CFTR (A1) were mostly found at the plasma membrane co-localizing with wheat germ agglutinin FIGURE 4.
X
ABCC7 p.Leu581Phe 20551307:201:13
status: NEWX
ABCC7 p.Leu581Phe 20551307:201:26
status: NEW202 Rescue of trafficking defect of K584E-CFTR by L581F-CFTR.
X
ABCC7 p.Leu581Phe 20551307:202:46
status: NEW203 A, biochemical analysis by Western blot of total protein extract from BHK cells stably expressing K584E (lane 1), L581F (lane 2), L581F/K584E (lane 3), WT (lane 4), F508del (lane 5), F508del at 26 °C (lane 6), and K584E at 26 °C (lane 7).
X
ABCC7 p.Leu581Phe 20551307:203:114
status: NEWX
ABCC7 p.Leu581Phe 20551307:203:130
status: NEW209 C, turnover and processing of WT-, F508del-, K584E-, L581F-, and L581F/K584E-CFTR determined in BHK cells stably expressing these CFTR variants by pulse-chase experiments followed by immunoprecipitation.
X
ABCC7 p.Leu581Phe 20551307:209:53
status: NEWX
ABCC7 p.Leu581Phe 20551307:209:65
status: NEW217 We interpret these data to suggest that L581F rescues the cell surface expression of K584E, confirming our biochemical and functional data, which argue that L581F-CFTR is a revertant mutant for K584E-CFTR.
X
ABCC7 p.Leu581Phe 20551307:217:40
status: NEWX
ABCC7 p.Leu581Phe 20551307:217:157
status: NEW219 We therefore speculated that L581F-CFTR might augment the single channel activity of K584E-CFTR.
X
ABCC7 p.Leu581Phe 20551307:219:29
status: NEW221 Fig. 6A demonstrates that addition of ATP (1 mM) and protein kinase A (75 nM) to the intracellular solution bathing excised inside-out membrane patches from cells expressing K584E-, L581F-, and L581F/K584E-CFTR cultured at 37 °C activated single channels with properties and regulation characteristic of wild-type CFTR.
X
ABCC7 p.Leu581Phe 20551307:221:182
status: NEWX
ABCC7 p.Leu581Phe 20551307:221:194
status: NEW224 Consistent with the behavior of other CFTR variants containing point mutations in the NBDs (2), K584E-, L581F-, and L581F/K584E-CFTR had values of i similar to that of WT-CFTR (Fig. 6B).
X
ABCC7 p.Leu581Phe 20551307:224:104
status: NEWX
ABCC7 p.Leu581Phe 20551307:224:116
status: NEW227 Visual inspection of single channel records suggested that the gating behavior of the CFTR variants K584E-, L581F-, and L581F/K584E-CFTR all resembled that of WT-CFTR (Fig. 6A).
X
ABCC7 p.Leu581Phe 20551307:227:108
status: NEWX
ABCC7 p.Leu581Phe 20551307:227:120
status: NEW228 Consistent with this idea, the Po of L581F/ K584E-CFTR was the same as that of WT-CFTR, whereas those of K584E- and L581F-CFTR were slightly, albeit significantly (p Ͻ 0.05), reduced (Fig. 6C).
X
ABCC7 p.Leu581Phe 20551307:228:37
status: NEWX
ABCC7 p.Leu581Phe 20551307:228:116
status: NEW234 Single channel analysis of CFTR constructs K584E-, L581F-, and L581F/K584E-CFTR.
X
ABCC7 p.Leu581Phe 20551307:234:51
status: NEWX
ABCC7 p.Leu581Phe 20551307:234:63
status: NEW237 For WT-, F508del-, K584E-, and L581F/ K584E-CFTR, membrane patches contained a single active channel, but for L581F-CFTR, the membrane patch contained two active channels.
X
ABCC7 p.Leu581Phe 20551307:237:31
status: NEWX
ABCC7 p.Leu581Phe 20551307:237:110
status: NEW244 Of note, these effects of K584E-CFTR were rescued by the revertant mutation L581F-CFTR.
X
ABCC7 p.Leu581Phe 20551307:244:76
status: NEW285 Among the 20 point mutants described in this study (the above 18 point mutants plus L581F and L581F/K584E), we found four that are listed in the CFTR mutation database (CFTR mutation database), namely E527Q, T1263I, and P1290T, which are described in association with mild CF, and I539T, which is described as an F508del-revertant mutation (Table 1).
X
ABCC7 p.Leu581Phe 20551307:285:84
status: NEWX
ABCC7 p.Leu581Phe 20551307:285:94
status: NEW289 The most striking differences for the NBD1 mutants (Table 1 and Fig. 2, compare C with D) were (Iodide efflux to processed protein (%) far right column) E527Q (64/46), I539T (112/49), and L581F (118/72), whereas for the NBD2 mutants, they were T1263I (75/31), K1302Q (72/37), Q1309K (79/26), S1311K (73/33), V1338T (88/37), L1367I (72/36), and E1409D (70/43).
X
ABCC7 p.Leu581Phe 20551307:289:188
status: NEW298 To investigate this discrepancy, we used our processing (Table 1) and single channel data (Fig. 6) to calculate predicted macroscopic currents for K584E-, L581F-, and L581F/K584E-CFTR and compared the values obtained with the magnitude of iodide efflux generated by these different CFTR constructs (Fig. 2C).
X
ABCC7 p.Leu581Phe 20551307:298:155
status: NEWX
ABCC7 p.Leu581Phe 20551307:298:167
status: NEW304 Thus, these data provide a molecular explanation for the quantitative decrease in CFTR-mediated iodide efflux caused by K584E and for the rescuing action of L581F.
X
ABCC7 p.Leu581Phe 20551307:304:157
status: NEW312 TABLE 2 Comparison of predicted and measured CFTR-mediated iodide efflux for K584E-, L581F-, and L581F/K584E-CFTR N, the number of Cl-channels in the cell membrane; i, single-channel current; N ϫ i ϫ Po, the predicted CFTR-mediated iodide efflux based on CFTR processing and single channel data; ICFTR , measured CFTR-mediated iodide efflux.
X
ABCC7 p.Leu581Phe 20551307:312:85
status: NEWX
ABCC7 p.Leu581Phe 20551307:312:97
status: NEW315 CFTR N i Po N ؋ i ؋ Po ICFTR % % % % % Wild type 100 100 100 100 100 F508del 5 104 12 1 0 K584E 1 90 73 1 0 L581F 107 88 81 75 72 L581F/K584E 100 91 103 93 100 Folding of CFTR Chimeras 27042 interacts with Leu581 .
X
ABCC7 p.Leu581Phe 20551307:315:120
status: NEWX
ABCC7 p.Leu581Phe 20551307:315:142
status: NEW318 The introduction of the L581F mutation likely restores the processing defect of K584E possibly mediated by the side chain of Phe581 that fills the empty space left by the removal of Lys584 .
X
ABCC7 p.Leu581Phe 20551307:318:24
status: NEW319 Moreover, confirmation that both L581F and L581F/K584E are present at the cell surface was provided by functional studies (both iodide efflux and patch clamp).
X
ABCC7 p.Leu581Phe 20551307:319:33
status: NEWX
ABCC7 p.Leu581Phe 20551307:319:43
status: NEW327 Moreover, by using the available structure of NBD1, we predicted that substitution of another NBD1 residue (L581F) should restore the processing defect of K584E.
X
ABCC7 p.Leu581Phe 20551307:327:108
status: NEW